KRAS mutation: from undruggable to druggable in cancer.
Signal Transduct Target Ther. 2021 Nov 15;6(1):386. doi: 10.1038/s41392-021-00780-4.
Signal Transduct Target Ther. 2021.
PMID: 34776511
Free PMC article.
Review.